[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 51, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 715350, "exercisedValue": 0, "unexercisedValue": 341880}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 598862, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.47, "open": 11.63, "dayLow": 11.5488, "dayHigh": 12.5489, "regularMarketPreviousClose": 11.47, "regularMarketOpen": 11.63, "regularMarketDayLow": 11.5488, "regularMarketDayHigh": 12.5489, "payoutRatio": 0.0, "beta": 1.949, "forwardPE": -4.2689652, "volume": 1906961, "regularMarketVolume": 1906961, "averageVolume": 1146251, "averageVolume10days": 2116070, "averageDailyVolume10Day": 2116070, "bid": 8.91, "ask": 14.87, "bidSize": 2, "askSize": 2, "marketCap": 1077617152, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 15.125, "allTimeHigh": 63.78, "allTimeLow": 2.09, "priceToSalesTrailing12Months": 85.5999, "fiftyDayAverage": 10.1997, "twoHundredDayAverage": 9.389725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 813723200, "profitMargins": 0.0, "floatShares": 70786741, "sharesOutstanding": 87045008, "sharesShort": 14973353, "sharesShortPriorMonth": 13763815, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.172, "heldPercentInsiders": 0.09957, "heldPercentInstitutions": 0.87069, "shortRatio": 14.41, "shortPercentOfFloat": 0.17969999, "impliedSharesOutstanding": 87045008, "bookValue": 3.095, "priceToBook": 4.0, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -212386000, "trailingEps": -3.05, "forwardEps": -2.9, "enterpriseToRevenue": 64.638, "enterpriseToEbitda": -4.319, "52WeekChange": -0.005622506, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 12.38, "targetHighPrice": 38.0, "targetLowPrice": 18.0, "targetMeanPrice": 24.0, "targetMedianPrice": 22.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 268036000, "totalCashPerShare": 3.079, "ebitda": -188419008, "totalDebt": 4142000, "quickRatio": 11.716, "currentRatio": 12.127, "totalRevenue": 12589000, "debtToEquity": 1.538, "revenuePerShare": 0.174, "returnOnAssets": -0.40195, "returnOnEquity": -0.81202006, "grossProfits": -120196000, "freeCashflow": -133341000, "operatingCashflow": -178683008, "revenueGrowth": 0.698, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -11.57609, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1759532907, "regularMarketTime": 1759521601, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "marketState": "CLOSED", "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.05, "epsForward": -2.9, "epsCurrentYear": -2.09, "priceEpsCurrentYear": -5.923445, "fiftyDayAverageChange": 2.1802998, "fiftyDayAverageChangePercent": 0.21376115, "twoHundredDayAverageChange": 2.9902754, "twoHundredDayAverageChangePercent": 0.31846252, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 7.93374, "regularMarketPrice": 12.38, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "postMarketChangePercent": 2.10016, "postMarketPrice": 12.64, "postMarketChange": 0.26, "regularMarketChange": 0.91, "regularMarketDayRange": "11.5488 - 12.5489", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1146251, "fiftyTwoWeekLowChange": 7.23, "fiftyTwoWeekLowChangePercent": 1.4038835, "fiftyTwoWeekRange": "5.15 - 15.125", "fiftyTwoWeekHighChange": -2.745, "fiftyTwoWeekHighChangePercent": -0.18148759, "fiftyTwoWeekChangePercent": -0.5622506, "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]